N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review

Published:2018-01 Issue: Volume:93 Page:112-119
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Clough Alexander J.,Hilmer Sarah N.,Naismith Sharon L.,Kardell Luke D.^ORCID,Gnjidic Danijela

Publisher

Elsevier BV

Subject

Epidemiology

Reference46 articles.

1. Clinical consequences of polypharmacy in elderly;Maher;Expert Opin Drug Saf,2014

2. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010;Guthrie;BMC Med,2015

3. Deprescribing: achieving better health outcomes for older people through reducing medications;Woodward;J Pharm Pract Res,2003

4. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis;Page;Br J Clin Pharmacol,2016

5. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review;Rodrigues;Rev Lat Am Enfermagem,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward;Epilepsia;2024-09-10

2. Deprescribing: An umbrella review;Acta Pharmaceutica;2024-05-30

3. A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges;International Journal of Qualitative Studies on Health and Well-being;2024-02-28

4. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper;European Geriatric Medicine;2023-10-09

5. Individual Treatment Trials—Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis?;Pharmaceuticals;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3